Literature DB >> 25670252

Basic science: hypertensive target organ damage.

Anil K Bidani, Karen A Griffin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25670252      PMCID： PMC4369441          DOI： 10.1016/j.jash.2015.01.005

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN： 1878-7436


× No keyword cloud information.
  9 in total

Review 1.  Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy.

Authors:  Michael F O'Rourke; Michel E Safar
Journal:  Hypertension       Date:  2005-05-23       Impact factor: 10.190

Review 2.  Hypertension and cerebrovascular dysfunction.

Authors:  Costantino Iadecola; Robin L Davisson
Journal:  Cell Metab       Date:  2008-06       Impact factor: 27.287

3.  How to best assess blood pressure? The ongoing debate on the clinical value of blood pressure average and variability.

Authors:  George S Stergiou; Gianfranco Parati
Journal:  Hypertension       Date:  2011-05-02       Impact factor: 10.190

Review 4.  Limitations of the usual blood-pressure hypothesis and importance of variability, instability, and episodic hypertension.

Authors:  Peter M Rothwell
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

Review 5.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.

Authors:  H Cai; D G Harrison
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367

Review 6.  Pathophysiology of hypertensive renal damage: implications for therapy.

Authors:  Anil K Bidani; Karen A Griffin
Journal:  Hypertension       Date:  2004-09-27       Impact factor: 10.190

Review 7.  Essential hypertension.

Authors:  Franz H Messerli; Bryan Williams; Eberhard Ritz
Journal:  Lancet       Date:  2007-08-18       Impact factor: 79.321

8.  Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study.

Authors:  Stanley S Franklin; Victor A Lopez; Nathan D Wong; Gary F Mitchell; Martin G Larson; Ramachandran S Vasan; Daniel Levy
Journal:  Circulation       Date:  2008-12-31       Impact factor: 29.690

Review 9.  Protective importance of the myogenic response in the renal circulation.

Authors:  Anil K Bidani; Karen A Griffin; Geoffrey Williamson; Xuemei Wang; Rodger Loutzenhiser
Journal:  Hypertension       Date:  2009-06-22       Impact factor: 10.190
  9 in total
  5 in total

1.  Early Onset Hypertension Is Associated With Hypertensive End-Organ Damage Already by MidLife.

Authors:  Karri Suvila; Elizabeth L McCabe; Arttu Lehtonen; Joseph E Ebinger; Joao A C Lima; Susan Cheng; Teemu J Niiranen
Journal:  Hypertension       Date:  2019-07-01       Impact factor: 10.190

Review 2.  Enhancing the Therapeutic Potential of Mesenchymal Stromal Cell-Based Therapies with an Anti-Fibrotic Agent for the Treatment of Chronic Kidney Disease.

Authors:  Yifang Li; Sharon D Ricardo; Chrishan S Samuel
Journal:  Int J Mol Sci       Date:  2022-05-27       Impact factor: 6.208

3.  Renal Perfusion Pressure Determines Infiltration of Leukocytes in the Kidney of Rats With Angiotensin II-Induced Hypertension.

Authors:  Satoshi Shimada; Justine M Abais-Battad; Ammar J Alsheikh; Chun Yang; Megan Stumpf; Theresa Kurth; David L Mattson; Allen W Cowley
Journal:  Hypertension       Date:  2020-08-03       Impact factor: 10.190

Review 4.  Effects of Caloric Restriction Diet on Arterial Hypertension and Endothelial Dysfunction.

Authors:  Nicola Di Daniele; Giulia Marrone; Manuela Di Lauro; Francesca Di Daniele; Daniela Palazzetti; Cristina Guerriero; Annalisa Noce
Journal:  Nutrients       Date:  2021-01-19       Impact factor: 5.717

5.  Prevalence of Hypertension in Ghana: Analysis of an Awareness and Screening Campaign in 2019.

Authors:  Elliot Koranteng Tannor; Obed Ofori Nyarko; Yaw Adu-Boakye; Saabea Owusu Konadu; Gilda Opoku; Frank Ankobea-Kokroe; Mercy Opare-Addo; Lambert Tetteh Appiah; Evans Xorse Amuzu; Gilgal Justice Ansah; Kate Appiah-Boateng; Emmanuel Ofori; Daniel Ansong
Journal:  Clin Med Insights Cardiol       Date:  2022-08-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.